Inställningar

Split view

Short keys for navigating in split view

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Dark Mode

Set dark mode to MFN.se

Sound

Plays a notification sound when new press release is published in the current feed

Intresserad av platformen MFN för nyhetsdistribution?

Onsdag 28 Oktober | 20:02:57 Europe / Stockholm

Svenska | English

Investor Relations

Public Relations

Redeye

Bifogade filer

CLS Q4 2022 - Important 2023 ahead

Prenumeration

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

CLS Q4 2022 - Important 2023 ahead

2023-02-24 09:15:00

Redeye provides an update in relation to CLS’ Q4 2022 report. The report did not include any major surprises in our view; however, we expect quarterly reports to become more interesting as we expect sales to ramp up during 2023. We have chosen not to make any changes in our future estimates; however, we update the current cash position and our capital raising assumptions, which results in a new fair value range.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/